A systematic review of preclinical studies exploring the role of insulin signalling in executive function and memory

Neurosci Biobehav Rev. 2023 Dec:155:105435. doi: 10.1016/j.neubiorev.2023.105435. Epub 2023 Oct 31.

Abstract

Beside its involvement in somatic dysfunctions, altered insulin signalling constitutes a risk factor for the development of mental disorders like Alzheimer's disease and obsessive-compulsive disorder. While insulin-related somatic and mental disorders are often comorbid, the fundamental mechanisms underlying this association are still elusive. Studies conducted in rodent models appear well suited to help decipher these mechanisms. Specifically, these models are apt to prospective studies in which causative mechanisms can be manipulated via multiple tools (e.g., genetically engineered models and environmental interventions), and experimentally dissociated to control for potential confounding factors. Here, we provide a narrative synthesis of preclinical studies investigating the association between hyperglycaemia - as a proxy of insulin-related metabolic dysfunctions - and impairments in working and spatial memory, and attention. Ultimately, this review will advance our knowledge on the role of glucose metabolism in the comorbidity between somatic and mental illnesses.

Keywords: Animal models; Comorbidity; Insulin signalling; Mental health; Systematic review.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Alzheimer Disease*
  • Executive Function
  • Humans
  • Insulin / metabolism
  • Obsessive-Compulsive Disorder*
  • Prospective Studies

Substances

  • Insulin